Cancer Institute A national cancer institute
designated cancer center

Michael Link

Publication Details

  • DOWN-REGULATED C-MYB EXPRESSION INHIBITS DNA-SYNTHESIS OF T-LEUKEMIA CELLS IN MOST PATIENTS CANCER RESEARCH Venturelli, D., MARIANO, M. T., Szczylik, C., Valtieri, M., Lange, B., Crist, W., Link, M., Calabretta, B. 1990; 50 (22): 7371-7375


    We have investigated the functional relevance of c-myb expression for DNA synthesis in patients' T-leukemia cells. [3H]Thymidine incorporation assays of 32 patients' leukemia cells exposed in vitro to c-myb sense or antisense oligodeoxynucleotides served to define two groups of patients: a responder group whose leukemia cells showed 2- to 16-fold lower levels of [3H]thymidine incorporation in c-myb antisense-treated cultures than in c-myb sense-treated cultures (20 patients) and a nonresponder group whose cells showed comparable [3H]thymidine incorporation levels in either c-myb sense- or antisense-treated cultures (12 patients). Down-regulation of c-myb mRNA levels in cells exposed to c-myb antisense oligodeoxynucleotides was comparable in both groups of patients, indicating that differential sensitivity to c-myb antisense oligodeoxynucleotides was not due to differential uptake of these oligodeoxynucleotides. DNA polymerase alpha mRNA levels were down-regulated in cells from the responders but were unaffected in the nonresponder group. These results suggest that c-myb is required for DNA synthesis in cells of many but not all T-leukemia patients and that leukemia cells in which DNA synthesis is not inhibited despite down-regulation of c-myb expression may have undergone some genetic change(s) that obviate(s) the requirement for myb protein.

    View details for Web of Science ID A1990EH00600045

    View details for PubMedID 2224864

Stanford Medicine Resources:

Footer Links: